Old Web
English
Sign In
Acemap
>
authorDetail
>
Ghazi Damanhouri
Ghazi Damanhouri
Ain Shams University
Gastroenterology
Thalassemia
Immunology
Deferasirox
Internal medicine
3
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and Safety of Once-Daily Oral Deferasirox (Exjade ® ) during a Median of 2.7 Years of Treatment in Heavily Iron-Overloaded Patients with β-Thalassemia
2008
Blood
Ali Taher
Amal El-Beshlawy
Mohsen Saleh Elalfy
Kusai Al Zir
Shahina Daar
Ghazi Damanhouri
D Habr
U Kriemler-Krahn
Abdel Hmissi
Abdullah Al Jefri
Show All
Source
Cite
Save
Citations (3)
Deferasirox (Exjade®) Treatment in Pediatric β-Thalassemia Patients with High Iron Burden: 2.8 Years Results from ESCALATOR Trial
2008
Blood
Ali Taher
Abdullah Al Jefri
Mohsen Saleh Elalfy
Kusai Al Zir
Shahina Daar
Ghazi Damanhouri
U Kriemler-Krahn
D Habr
Abdel Hmissi
Amal El-Beshlawy
Show All
Source
Cite
Save
Citations (1)
Deferasirox (Exjade®, ICL670) Is Effective and Tolerable in β-Thalassemia Patients with High Iron Burden and History of Inadequate Chelation Therapy.
2006
Blood
Ali Taher
A El-Beshlawy
A. Al Jefri
Mohsen Saleh Elalfy
K Al Zir
Shahina Daar
Ghazi Damanhouri
U. Krahn
D. Hadler
Show All
Source
Cite
Save
Citations (1)
1